Guobang Pharma Ltd (605507) — Financial Flexibility Index
Guobang Pharma Ltd (605507) has a Financial Flexibility Index of 0.18x as of September 2025. Free cash flow of CN¥421.85 Million (operating CF CN¥311.27 Million minus capex CN¥110.58 Million) represents 0% of total liabilities (CN¥2.30 Billion). Also explore Guobang Pharma Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Guobang Pharma Ltd Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Guobang Pharma Ltd across 9 annual periods. Check how resilient are Guobang Pharma Ltd's assets to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Guobang Pharma Ltd (2017–2025)
Year-by-year free cash flow to debt coverage for Guobang Pharma Ltd. For the full company profile including market capitalisation, see 605507 market cap.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.34x | CN¥836.99 Million | CN¥559.28 Million | CN¥2.43 Billion | ▼ -16.5% |
| 2024 | 0.41x | CN¥1.13 Billion | CN¥706.41 Million | CN¥2.73 Billion | ▼ -4.6% |
| 2023 | 0.43x | CN¥1.27 Billion | CN¥516.76 Million | CN¥2.92 Billion | ▼ -55.1% |
| 2022 | 0.96x | CN¥1.82 Billion | CN¥1.02 Billion | CN¥1.89 Billion | ▲ +313.8% |
| 2021 | 0.23x | CN¥271.86 Million | CN¥-176.18 Million | CN¥1.17 Billion | ▼ -59.6% |
| 2020 | 0.58x | CN¥1.29 Billion | CN¥767.70 Million | CN¥2.23 Billion | ▲ +18.1% |
| 2019 | 0.49x | CN¥1.05 Billion | CN¥440.86 Million | CN¥2.14 Billion | ▲ +22.8% |
| 2018 | 0.40x | CN¥704.93 Million | CN¥541.68 Million | CN¥1.77 Billion | ▲ +127.3% |
| 2017 | 0.17x | CN¥317.51 Million | CN¥148.03 Million | CN¥1.82 Billion | — |